Pimentel Aline de Castro, Scorsatto Mauara, de Oliveira Gláucia Maria Moraes, Rosa Glorimar, Luiz Ronir Raggio
Cardiology Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Josué de Castro Nutrition Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Nutrition. 2015 Jun;31(6):827-33. doi: 10.1016/j.nut.2014.12.024. Epub 2015 Jan 10.
The aim of this study was to identify metabolically healthy obese individuals (MHOs) and their characteristics, as well as to estimate cardiovascular risk using the Framingham score.
In all, 258 adult individuals, with body mass index ≥30 kg/m(2), and no report of diabetes mellitus or cardiovascular disease, were classified according to their metabolic state considering two criteria: rhe National Cholesterol Education Program-Adult Treatment Panel III (NCEP-ATP III) and the homeostasis model assessment (HOMA). Biochemical, anthropometric, and body composition characteristics were compared between MHOs and metabolically unhealthy obese (MUO) individuals according to each criterion. Cardiovascular risk was estimated using the Framingham score.
MHOs exhibited smaller waist circumference and lower body fat percentage, as well as lower blood glucose, triacylglycerols, and insulin levels, in addition to higher high-density lipoprotein cholesterol concentration, when HOMA criterion (P < 0.05) and associated criteria were adopted. The estimated cardiovascular risk was similar between the two groups according to the HOMA index; however, the risk was significantly lower according to the ATP III guidelines. Obese individuals at intermediate and high risk showed higher body fat percentage compared with those individuals at low risk.
MHOs had biochemical and anthropometric characteristics, such as lower body mass index, waist circumference, percent fat mass, glucose, triacylglycerols, and increased high-density lipoprotein, that made them different from those individuals classified as MUO. The latter exhibited increased risk for cardiovascular disease according to the Framingham score, when using the ATP III criterion alone or in conjunction with the HOMA index.
本研究旨在识别代谢健康的肥胖个体(MHO)及其特征,并使用弗雷明汉评分评估心血管风险。
共有258名体重指数≥30kg/m²且无糖尿病或心血管疾病报告的成年人,根据其代谢状态,采用两个标准进行分类:美国国家胆固醇教育计划成人治疗小组第三次报告(NCEP-ATP III)和稳态模型评估(HOMA)。根据每个标准,比较MHO与代谢不健康肥胖(MUO)个体之间的生化、人体测量和身体成分特征。使用弗雷明汉评分评估心血管风险。
当采用HOMA标准(P<0.05)及相关标准时,MHO的腰围较小、体脂百分比较低,此外血糖、三酰甘油和胰岛素水平较低,高密度脂蛋白胆固醇浓度较高。根据HOMA指数,两组的估计心血管风险相似;然而,根据ATP III指南,风险显著较低。与低风险个体相比,中高风险的肥胖个体体脂百分比更高。
MHO具有生化和人体测量学特征,如较低的体重指数、腰围、体脂百分比、血糖、三酰甘油,以及升高的高密度脂蛋白,这使其与被归类为MUO的个体不同。当单独使用ATP III标准或与HOMA指数结合使用时,根据弗雷明汉评分,后者患心血管疾病的风险增加。